Fig. 2From: Cost-effectiveness of voretigene neparvovec in the treatment of patients with inherited retinal disease with RPE65 mutation in SwitzerlandTornado diagram for univariate sensitivity analysis. KEY: CHF, Swiss francs; HS, health state; ICER, incremental cost-effectiveness ratio; VA, visual acuity; VF, visual functionBack to article page